The Cancer Prevention Network (CPN) was founded in 2003 by pioneering physicians from throughout United States, Canada, and the Mayo Clinic in Rochester, Minnesota. These physicians saw a need to find novel means of improving quality of life through cancer prevention, particularly for diseases for which treatment still offers a relatively poor prognosis. CPN seeks relatively healthy adults who are at increased risk for these types of cancer for participation in Phase I and Phase II clinical trials. In order to bring high-quality cancer research to the communities where patients live and receive most of their medical care, they formed a cancer clinical trials cooperative group. This cooperative group allows promising scientific ideas developed at Mayo Clinic to be tested in many communities throughout CPN. Therefore, there will be numbers of research subjects sufficient to ensure meaningful and powerful research data.
Today, CPN has grown to include more than 60 specialists at community clinics and medical centers in 19 states and two Canadian provinces, with a research base at Mayo Clinic in Rochester, Minn. CPN receives much of its scientific and financial support through the National Cancer Institute.
For more information, contact CPN's Operations Office.